# Relay Therapeutics, Inc.: filings

RLAY · Nasdaq · CIK 1812364 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rlay.md) · [Financials](/companies/rlay/financials.md) · [Filings](/companies/rlay/filings.md) · [Insiders](/companies/rlay/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 292, 8-K 63, 144 39, 3 21, 10-Q 19, SC 13G/A 12, SCHEDULE 13G/A 12, 424B5 9, CORRESP 7, S-8 7, SC 13G 7, 10-K 6, 4/A 6, DEF 14A 6, DEFA14A 6, 424B7 5, SCHEDULE 13G 5, ARS 4, S-1/A 4, UPLOAD 4, 424B4 2, EFFECT 2, PRE 14A 2, S-1 2, S-3ASR 2, 5 1, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:15 ET | [10-Q](/filings/0001193125-26-338056.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338056 |
| 2026-08-06 | 16:11 ET | [8-K](/filings/0001193125-26-338013.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338013 |
| 2026-06-09 | 16:35 ET | [8-K](/filings/0001193125-26-263873.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-263873 |
| 2026-05-21 | 17:07 ET | [8-K](/filings/0001193125-26-234862.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-234862 |
| 2026-05-19 | 08:45 ET | [8-K](/filings/0001193125-26-229770.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229770 |
| 2026-05-05 | 16:15 ET | [10-Q](/filings/0001193125-26-206454.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206454 |
| 2026-05-05 | 16:10 ET | [8-K](/filings/0001193125-26-206398.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206398 |
| 2026-04-28 | 16:05 ET | [DEF 14A](/filings/0001193125-26-186929.md) | Proxy statement, period 2026-06-09 | 0001193125-26-186929 |
| 2026-04-27 | 09:15 ET | [8-K](/filings/0001193125-26-179404.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-179404 |
| 2026-03-16 | 08:30 ET | [8-K](/filings/0001193125-26-107312.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-107312 |
| 2026-03-11 | 16:15 ET | [8-K](/filings/0001193125-26-102178.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-102178 |
| 2026-02-26 | 16:16 ET | [10-K](/filings/0001193125-26-076739.md) | Annual report, period 2025-12-31 | 0001193125-26-076739 |
| 2026-02-26 | 16:10 ET | [8-K](/filings/0001193125-26-076617.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076617 |
| 2026-02-03 | 07:10 ET | [8-K](/filings/0001193125-26-034422.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-034422 |
| 2025-11-06 | 16:18 ET | [10-Q](/filings/0001193125-25-269601.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269601 |
| 2025-11-06 | 16:12 ET | [8-K](/filings/0001193125-25-269536.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-269536 |
| 2025-08-07 | 16:17 ET | [10-Q](/filings/0000950170-25-105054.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105054 |
| 2025-08-07 | 16:10 ET | [8-K](/filings/0000950170-25-105022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105022 |
| 2025-06-11 | 16:12 ET | [8-K](/filings/0001193125-25-139146.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-139146 |
| 2025-06-06 | 17:00 ET | [8-K](/filings/0001193125-25-137162.md) | 5.07 Shareholder vote results | 0001193125-25-137162 |
| 2025-06-04 | 16:15 ET | [8-K](/filings/0001193125-25-134908.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-25-134908 |
| 2025-05-05 | 16:15 ET | [10-Q](/filings/0000950170-25-063553.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063553 |
| 2025-05-05 | 16:10 ET | [8-K](/filings/0000950170-25-063539.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063539 |
| 2025-04-23 | 16:05 ET | [DEF 14A](/filings/0000950170-25-057333.md) | Proxy statement, period 2025-06-06 | 0000950170-25-057333 |
| 2025-02-26 | 16:15 ET | [10-K](/filings/0000950170-25-027756.md) | Annual report, period 2024-12-31 | 0000950170-25-027756 |
| 2025-02-26 | 16:10 ET | [8-K](/filings/0000950170-25-027733.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027733 |
| 2025-01-13 | 08:30 ET | [8-K](/filings/0000950170-25-004586.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004586 |
| 2024-12-11 | 07:00 ET | [8-K](/filings/0000950170-24-135207.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135207 |
| 2024-11-06 | 16:15 ET | [10-Q](/filings/0000950170-24-122332.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122332 |
| 2024-11-06 | 16:10 ET | [8-K](/filings/0000950170-24-122297.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122297 |
| 2024-09-11 | 16:49 ET | [8-K](/filings/0001193125-24-217296.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217296 |
| 2024-09-09 | 08:00 ET | [8-K](/filings/0000950170-24-104557.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-104557 |
| 2024-08-06 | 16:15 ET | [10-Q](/filings/0000950170-24-091837.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091837 |
| 2024-08-06 | 16:10 ET | [8-K](/filings/0000950170-24-091802.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091802 |
| 2024-07-16 | 16:15 ET | [8-K](/filings/0000950170-24-083928.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-083928 |
| 2024-06-06 | 08:00 ET | [8-K](/filings/0000950170-24-069674.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-069674 |
| 2024-06-03 | 16:05 ET | [8-K](/filings/0000950170-24-067952.md) | 5.07 Shareholder vote results | 0000950170-24-067952 |
| 2024-05-02 | 16:15 ET | [10-Q](/filings/0000950170-24-052135.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052135 |
| 2024-05-02 | 16:10 ET | [8-K](/filings/0000950170-24-052110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052110 |
| 2024-04-23 | 16:05 ET | [DEF 14A](/filings/0000950170-24-046883.md) | Proxy statement, period 2024-06-03 | 0000950170-24-046883 |
| 2024-02-22 | 16:16 ET | [10-K](/filings/0000950170-24-018797.md) | Annual report, period 2023-12-31 | 0000950170-24-018797 |
| 2024-02-22 | 16:10 ET | [8-K](/filings/0000950170-24-018763.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-018763 |
| 2024-01-08 | 07:05 ET | [8-K](/filings/0000950170-24-002682.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002682 |
| 2023-11-02 | 16:17 ET | [10-Q](/filings/0000950170-23-058237.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058237 |
| 2023-11-02 | 16:10 ET | [8-K](/filings/0000950170-23-058199.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-058199 |
| 2023-10-12 | 16:13 ET | [8-K](/filings/0000950170-23-053109.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-053109 |
| 2023-08-08 | 16:25 ET | [10-Q](/filings/0000950170-23-039874.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039874 |
| 2023-08-08 | 16:14 ET | [8-K](/filings/0000950170-23-039822.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-039822 |
| 2023-05-31 | 16:05 ET | [8-K](/filings/0000950170-23-025321.md) | 5.07 Shareholder vote results | 0000950170-23-025321 |
| 2023-05-25 | 17:05 ET | [8-K](/filings/0000950170-23-024290.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-024290 |

Page 1 of 2. [Older](/companies/rlay/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:27 ET. No prices; not investment advice.